Hims & Hers Under Fire, Stock Tanks on Federal Crackdown, Patent War

Shares of Hims & Hers crashed to new 52-week lows on Monday, under the weight of much uncertainty. HIMS stock is dropping. See the chart and price action here. Federal Crackdown: FDA & DOJOne catalyst for the crash was Hims’ recent aggressive attempt to launch a compounded oral semaglutide pill — a copycat of Novo Nordisk A/S’s (NYSE:NVO) newly approved oral Wegovy. The response from Washington was swift and severe:Under regulatory pressure, Hims & Hers did a U-turn on Saturday and announced it would stop o ...